falsefalse

Key Data Updates and Treatment Trends in Ovarian Cancer From ASCO 2025 - Episode 2

Data for First-Line Dostarlimab and Niraparib in Advanced Ovarian Cancer: The FIRST Trial

,

Tara Berman, MD, MS, and Gottfried E. Konecny, MD, discuss data for dostarlimab plus niraparib in advanced ovarian cancer.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    x